The enrichment of pathway on cell cycle control upon silencing PKD2 or PKD2&3 gives a mechanistic explanation to the observation that silencing PKD2 or PKD3 inhibits proliferation of breast cancer cell and reduced breast tumor burden. The gene discussed is PKD2; the disease is breast neoplasm.